#077: Tailoring MS Treatment. The Impact of Mood Disorders on Patient Care with Dr. Emine Rabia Koç

#077: Tailoring MS Treatment. The Impact of Mood Disorders on Patient Care with Dr. Emine Rabia Koç

Explore Dr. Emine Rabia Koç's insights on blending emotional and physical health for a holistic approach to MS treatment.

You can find the written version as blog article here: https://ms-perspektive.com/77-emine-rabia-koc

Today I speak with Dr. Emine Rabia Koç about the important intersection between mood disorders and patient care in multiple sclerosis. As an associate professor at Uludağ University Faculty of Medicine and a dedicated neurologist, Dr. Koç brings a wealth of knowledge and compassion to the MS community.

In this interview, Dr. Koç discusses the profound impact that mood disorders have on MS treatment and patient well-being. From her personal journey into the field of neuroimmunology to practical advice for patients and caregivers, Dr. Koç provides insights that underscore the importance of comprehensive care strategies that address both the physical and emotional facets of living with MS.

Introduction – Who is Emine Rabia Koç?

Thank you for the invitation. I am Emine Rabia Koç, Associate Professor at Uludağ University, Faculty of Medicine, Department of Neurology. Working in the field of neurology is a passion for me. During my neurology residency, neuroimmunology and autoimmune diseases of the nervous system were areas that particularly interested me. After completing my residency, I started working and doing research in this field. The more I learned, the more I loved it, and I continued my education and training in this field. Since 2022, I have been a student in the MS Master program organized in partnership with the University of Dresden and the European Charcot MS Foundation.

I am also an ambassador for the Sumaira Foundation, the voice of NMOSD and MOGAD patients worldwide.

I try to balance my life in this cycle; I am married and have two children. The moments I spend with them are precious to me. I like walking in nature, swimming, cycling, reading books, and visiting different places and cultures in my free time.

How and where can interested people follow your research activities?

If you're interested in following my research activities, you can find updates on my work through my university's website and social media platforms. I also regularly share insights and findings on LinkedIn (Emine Rabia Koç),instagram(drkocrabia) where I engage with the MS community. I encourage everyone to stay connected, as collaboration and communication are key to advancing our understanding of MS.

---

Many thanks to Rabia for giving us some insight views into the interaction of mood disorders and MS and for all her efforts that contribute in better health outcomes for her patients.

See you soon and try to make the best out of your life,
Nele

For more information and positive thoughts, subscribe to my newsletter for free.

Click here for an overview of all podcast episodes published so far.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(193)

#191: BTK inhibitors in MS: where do we stand after ECTRIMS/ACTRIMS 2026?

#191: BTK inhibitors in MS: where do we stand after ECTRIMS/ACTRIMS 2026?

BTK inhibitors have produced different results in multiple sclerosis trials. In episode no. 191, I explore what we learned at ECTRIMS/ACTRIMS 2026 about individual medicines, their potential benefits ...

11 Nov 19min

#190: Living with multiple sclerosis. Gabriela's story and the "(un)seen faces of MS" Art Project

#190: Living with multiple sclerosis. Gabriela's story and the "(un)seen faces of MS" Art Project

https://ms-perspektive.de/en/190-unseen-faces-of-ms/Living with multiple sclerosis often means experiencing symptoms that others cannot see. Austrian artist Gabriela Romagna shares her journey to an M...

4 Nov 32min

#189: New imaging in MS: understanding progression and finding better treatments | ECTRIMS 2026

#189: New imaging in MS: understanding progression and finding better treatments | ECTRIMS 2026

How could new imaging in MS help us understand progression and develop better treatments? In this episode, I explore key insights from Daniel Reich's MSToronto2026 lecture and related research. Learn ...

28 Okt 15min

#188: Jan Van Amstel on EMSP's Four-Year Presidency and the Future of MS Advocacy in Europe

#188: Jan Van Amstel on EMSP's Four-Year Presidency and the Future of MS Advocacy in Europe

"Get rid of MS as soon as possible and make ourselves superfluous." — Jan van Amstel What can a stronger European voice achieve for people living with MS? In episode #188, EMSP President Jan van Amste...

21 Okt 31min

#187: Aging in multiple sclerosis: relapses, progression and treatment choices with Dr. Yi Chao Foong

#187: Aging in multiple sclerosis: relapses, progression and treatment choices with Dr. Yi Chao Foong

Aging in multiple sclerosis brings new questions about relapses, gradual progression and treatment choices. In episode 187, Dr. Yi Chao Foong, an MS neurologist and researcher in Tasmania, explains wh...

14 Okt 29min

#186: Protecting nerve cells in multiple sclerosis: A new path toward neuroprotection with Prof. Manuel Friese

#186: Protecting nerve cells in multiple sclerosis: A new path toward neuroprotection with Prof. Manuel Friese

Why can multiple sclerosis progress even when relapses are well controlled? In episode 186, I speak with Prof. Manuel Friese about the next challenge in MS research: protecting nerve cells from damage...

7 Okt 43min

#185: Living with MS in Mexico – who gets diagnosed, who gets treated, and who gets left behind?

#185: Living with MS in Mexico – who gets diagnosed, who gets treated, and who gets left behind?

An MS diagnosis can depend on where you live, whether you can reach a neurologist and how quickly you can get an MRI. In this episode, Nele speaks with neurologist and neuroimmunologist Dr. Enrique Go...

30 Sep 36min

#184: MS treatment across the disease course – treat early, think long-term, don't give up too soon with Prof. Klaus Schmierer

#184: MS treatment across the disease course – treat early, think long-term, don't give up too soon with Prof. Klaus Schmierer

Read the full blog post and interview here: https://ms-perspektive.de/en/184-klaus-schmierer/ How early should MS treatment start, how strongly should we treat, and is there ever a point when it becom...

23 Sep 41min

Populärt inom Utbildning

husmodern-med-amanda-schulman
historiepodden-se
det-skaver
rosceremoni
rss-bara-en-till-om-beroende-medberoende
nu-blir-det-historia
harrisons-dramatiska-historia
rss-viktmedicinpodden
not-fanny-anymore
roda-vita-rosen
rss-dr-bjorklund
i-vantan-pa-katastrofen
allt-du-velat-veta
sektledare
sa-in-i-sjalen
rss-basta-livet
johannes-hansen-podcast
rss-traningsklubben
sektpodden
rss-max-tant-med-max-villman